Vertex Pharmaceuticals Inc. insider trades
as of filings through Nov 10, 2026
- Bought
- $0
- 0 trades, 0 insiders
- Sold
- $6.31M
- 1 trade, 1 insider
- Net
- −$6.31M
- since Nov 10, 2026
- Under 10b5-1 plans
- 1
- of 1 sale
FiledStockInsiderSideValueSharesAvg priceTraded
- Filed Nov 10, 4:20 PM (the Form 4 at the SEC), traded Nov 6 · 4d late to fileVRTXSoldReshma Kewalramani · CEO & President, DirectorPlan$6.3M